Delivery Order SPE2DB20D1100-SPE2DB25FD6Q0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Verquvo 10 mg tablets (quantity 90) at a firm fixed price of $12,569.21, with completion targeted for September 3, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Verquvo 10 mg tablets (30-count units) with a ceiling value of $2,449.20. This firm fixed price delivery order, set to be completed by September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,851.91 to AmerisourceBergen Drug Corp for VERQUVO 2.5 mg tablets (30-count supply) on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a small-value pharmaceutical transaction within the company's broader federal contract portfolio. The award will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,849.00 delivery order to AmerisourceBergen Drug Corp for VERQUVO 2.5 mg tablets (30 count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- This delivery order awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $1,049.21 for the supply of Verquvo 2.5 mg tablets (30-count) under a competitive, non-set-aside procurement. The Defense Logistics Agency, which manages pharmaceutical supply chains for the Department of Defense, issued this award with an ultimate completion date of August 8, 2025. The contractor will perform this delivery from its corporate office in Conshohocken, Pennsylvania, where...
- This federal contract award, valued at $2,854.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VERQUVO 5 MG TABLET 30S, a pharmaceutical product, and has an ultimate completion date of June 10, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract was not designated with a set-aside requirement, indicating open...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of Verquvo 10 mg tablets, a cardiovascular medication. The contract has a ceiling value of $1,004.82 and a period of performance through November 4, 2024. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,705.63, is for the delivery of the drug VERQUVO 10 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. The contract was awarded on October 25, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VERQUVO 5 MG Tablets. The $1,041.29 order is for pharmaceutical products to be delivered to a location in Conshohocken, Pennsylvania by December 26, 2023. As a prime contractor, Amerisourcebergen Drug Corp has a history of supplying pharmaceuticals, medical supplies, and related distribution services to support DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,532.49 delivery order contract is for the supply of the prescription medication VERQUVO 10 MG TABLET 30S. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6Q0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,721.73 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this requirement as a critical vendor supporting federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/25/25 |